Related Experiment Video
Updated: Mar 24, 2026

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice
Published on: August 23, 2019
MicroRNA-183 Functions As an Oncogene by Regulating PDCD4 in Gastric Cancer
Chenglong Li, Li Deng, Qiaoming Zhi
1Department of General Surgery and Translational Medicine Center, Nanjing Medical University Affiliated Wuxi Second Hospital, Wuxi, 214002, China. jiazengxia@yahoo.com.
Abstract:
MicroRNA-183 (miR-183) has recently been identified to be implicated in a variety of critical processes in multiple human malignancies, and its fuction has been poorly characterized in gastric cancer (GC). Here we reported that miR-183 was markedly over-expressed in GC and its up-regulation was markedly associated with GC clinicopathologicalcharacters. Endogenous miR-183 was inhibited in GC cells, which dramatically attenuated cell proliferation, colony formation, migration, invasion and adhesion and enhancedGC cells apoptosis in vitro. Furthermore, in this study we demonstrated that the tumor suppressor gene PDCD4 was a target of miR-183 in GC. Collectively, these observations showed that miR-183 maybe function as an oncogene by regulating GC cell proliferation, apoptosis and metastasis and the oncogenic effect of miR-183 may relate the direct targeting PDCD4.
Insights
MicroRNA-183 (miR-183) is over-expressed in gastric cancer (GC), promoting tumor growth and metastasis. Inhibiting miR-183 suppressed GC cell progression by targeting the PDCD4 gene, suggesting miR-183 acts as an oncogene in GC.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- MicroRNA-183 (miR-183) plays a role in various human cancers, but its function in gastric cancer (GC) is not well understood.
- Gastric cancer remains a significant global health challenge with a need for better understanding of its molecular drivers.
Purpose of the Study:
- To investigate the role and mechanism of miR-183 in gastric cancer.
- To determine the association between miR-183 expression and GC clinicopathological features.
Main Methods:
- Quantitative real-time PCR to measure miR-183 expression in GC tissues and cells.
- In vitro assays including cell proliferation, colony formation, migration, invasion, adhesion, and apoptosis assays.
- Western blot and luciferase reporter assays to validate PDCD4 as a direct target of miR-183.
Main Results:
- miR-183 was significantly over-expressed in GC tissues and associated with advanced clinicopathological characteristics.
- Inhibition of endogenous miR-183 in GC cells reduced proliferation, colony formation, migration, invasion, and adhesion, while enhancing apoptosis.
- PDCD4 was identified as a direct downstream target of miR-183 in GC cells.
Conclusions:
- miR-183 functions as an oncogene in gastric cancer by promoting cell proliferation, survival, and metastasis.
- The oncogenic role of miR-183 in GC is mediated, at least in part, through the direct targeting of the tumor suppressor gene PDCD4.
Related Concept Videos
MicroRNAs
MicroRNAs
Abnormal Proliferation
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...

